,使

Esther Redin1, Nerea Otegui1, Mirentxu Santos2

  • 1University of Navarra, Pamplona, Spain.

Cancer research
|July 25, 2025
PubMed
概括

将达沙替尼与免疫检查点阻塞相结合,可以增强小细胞肺癌 (SCLC) 的抗瘤免疫力. 这种结合疗法,涉及达沙替尼 (Dasa) 和免疫检查点阻断 (ITc),通过调节T细胞,抗原呈现细胞和自然杀手细胞,显示出卓越的疗效,CCL5作为潜在的反应生物标志物.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K